LAZZAROTTO, TIZIANA
 Distribuzione geografica
Continente #
AS - Asia 15.079
NA - Nord America 13.555
EU - Europa 12.254
SA - Sud America 913
AF - Africa 687
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 4
Totale 42.530
Nazione #
US - Stati Uniti d'America 13.323
IT - Italia 4.729
SG - Singapore 4.187
CN - Cina 3.910
VN - Vietnam 3.731
GB - Regno Unito 1.641
SE - Svezia 1.216
DE - Germania 1.172
HK - Hong Kong 986
FR - Francia 684
IN - India 655
BR - Brasile 640
KR - Corea 450
RU - Federazione Russa 440
UA - Ucraina 433
NL - Olanda 388
IE - Irlanda 346
FI - Finlandia 341
JP - Giappone 261
ZA - Sudafrica 200
CI - Costa d'Avorio 166
AT - Austria 131
CA - Canada 130
AR - Argentina 119
CH - Svizzera 119
EE - Estonia 112
PH - Filippine 104
ID - Indonesia 102
BG - Bulgaria 101
JO - Giordania 100
TG - Togo 98
TH - Thailandia 98
BE - Belgio 76
BD - Bangladesh 73
PL - Polonia 73
MX - Messico 66
TR - Turchia 64
NG - Nigeria 63
SC - Seychelles 62
IQ - Iraq 60
TW - Taiwan 50
ES - Italia 48
PK - Pakistan 46
EC - Ecuador 39
CO - Colombia 34
SA - Arabia Saudita 34
IR - Iran 33
AU - Australia 32
LT - Lituania 31
GR - Grecia 29
MY - Malesia 24
RO - Romania 24
HR - Croazia 21
VE - Venezuela 20
EG - Egitto 19
UZ - Uzbekistan 19
PE - Perù 17
CL - Cile 15
PT - Portogallo 15
CZ - Repubblica Ceca 14
LB - Libano 14
PY - Paraguay 14
SK - Slovacchia (Repubblica Slovacca) 14
MA - Marocco 12
DK - Danimarca 11
RS - Serbia 11
DZ - Algeria 10
KE - Kenya 9
GH - Ghana 8
KZ - Kazakistan 8
NP - Nepal 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
NO - Norvegia 7
UY - Uruguay 7
IL - Israele 6
AF - Afghanistan, Repubblica islamica di 5
GT - Guatemala 5
HU - Ungheria 5
JM - Giamaica 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
CY - Cipro 4
ET - Etiopia 4
GY - Guiana 4
KW - Kuwait 4
LK - Sri Lanka 4
MZ - Mozambico 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CM - Camerun 3
HN - Honduras 3
KH - Cambogia 3
Totale 42.468
Città #
Singapore 2.868
Ashburn 1.601
Southend 1.313
Fairfield 969
Hefei 958
Chandler 932
Hong Kong 924
Ho Chi Minh City 860
Hanoi 806
San Jose 727
Santa Clara 662
Houston 653
Woodbridge 522
Bologna 517
Wilmington 464
Seattle 457
Beijing 450
Princeton 411
Seoul 399
Milan 397
Rome 378
Cambridge 367
Ann Arbor 366
Dublin 342
Boardman 321
Dong Ket 300
Lauterbourg 258
Los Angeles 255
Dallas 254
Helsinki 244
Tokyo 221
Council Bluffs 214
Jacksonville 201
Abidjan 166
New York 165
Nanjing 155
Padova 154
Westminster 135
Turin 128
Da Nang 121
Haiphong 120
Berlin 116
Buffalo 111
Florence 110
Frankfurt am Main 110
Redondo Beach 103
Amman 99
Lomé 98
Sofia 96
São Paulo 90
Bengaluru 86
Vienna 84
Jinan 83
Shanghai 83
Chicago 80
San Diego 80
Naples 78
Bern 70
Shenyang 68
Guangzhou 67
Changsha 65
Hangzhou 65
Redmond 65
Brussels 63
Munich 63
Verona 63
Bremen 62
Des Moines 62
Amsterdam 60
Saint Petersburg 60
Johannesburg 58
Abeokuta 56
The Dalles 53
Jakarta 51
Lappeenranta 51
Mülheim 50
London 49
Nuremberg 49
Bari 47
Hải Dương 47
Zhengzhou 47
Tianjin 46
Hebei 44
Toronto 43
Falkenstein 40
Phoenix 40
Bangkok 39
Can Tho 39
Medford 37
Redwood City 37
Biên Hòa 36
Orem 36
Brooklyn 35
Montreal 35
Nanchang 35
Turku 35
Jiaxing 33
Catania 32
Paris 32
Baghdad 31
Totale 25.358
Nome #
Outcome delle gravidanze con infezione non primaria da CMV 2.311
La gestione clinica dell’infezione da citomegalovirus in gravidanza 465
Citomegalovirus 442
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 368
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 322
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions 273
Restriction Factors expression decreases in HIV-1 patients after cART 269
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 268
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 257
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 246
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 246
Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection 245
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 237
Altered intracellular ATP production by activated CD4+ T-cells in very preterm infants 234
Pathological post-mortem findings in lungs infected with SARS-CoV-2 228
Understanding the evolutionary dynamics of Monkeypox virus through less explored pathways 227
Brain damage in fetuses congenitally infected by Cytomegalovirus 226
Automatic environmental disinfection with hydrogen peroxide and silver ions versus manual environmental disinfection with sodium hypochlorite: A multicentre randomized before-and-after trial. 221
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 219
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 213
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 210
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study 202
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 201
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 200
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 195
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 194
Histological findings in foetuses congenitally infected by cytomegalovirus. 191
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 189
SARS-CoV-2/COVID-19 testing: The tower of babel 189
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. 187
Congenital Cytomegalovirus Infection: Prognostic Value of Maternal DNAemia at Amniocentesis. 187
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. 186
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 186
Atypical forms of hand, foot, and mouth disease: A prospective study of 47 Italian children 186
Cytomegalovirus DNA load in amniotic fluid and neonatal outcome. 185
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 183
Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. 181
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 181
Congenital cytomegalovirus infection: patterns of fetal brain damage. 180
Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection 180
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 179
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 179
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 178
Fetal Brain Damage in Human Fetuses with Congenital Cytomegalovirus Infection: Histological Features and Viral Tropism 178
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 177
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 176
DIAGNOSI ISTOLOGICA DI INFEZIONE FETALE DA CITOMEGALOVIRUS UMANO 175
Congenital cytomegalovirus infection and small for gestational age infants 175
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 174
Salivary glands and human congenital cytomegalovirus infection: What happens in early fetal life? 173
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 172
COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies 171
Herpes virus in Alzheimer's disease: relation to progression of the disease 171
Diagnosis and prognosis of congenital CMV infection: A case report and review of the literature 171
Neonatal and long-term ophthalmological findings in infants with symptomatic and asymptomatic congenital cytomegalovirus infection. 171
L’INFEZIONE CONGENITA DA CYTOMEGALOVIRUS NELLA GRAVIDANZA GEMELLARE 170
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 169
Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant. 169
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 168
Outcome della gravidanza dopo riscontro precoce di vaginosi batterica. 168
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. 168
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 168
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 168
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 167
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 166
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 165
Cytomegalovirus gN Genotypes Distribution among Congenitally Infected Newborns and Their Relationship with Symptoms at Birth and Sequelae. 165
Risposta immune nei feti con infezione da citomegalovirus umano e correlazione con il danno d’organo. 164
Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay 163
Congenital Human Cytomegalovirus Infection: Identification Of New Prognostic Markers Of Brain Damage In Infected Fetuses 163
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 162
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. 162
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 162
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 162
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 161
Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. 161
Measles virus and cytomegalovirus co-infection, in a child with recent SARS-CoV-2 infection, during COVID-19 pandemic: a case report 160
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 160
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection. 160
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 160
Immune Monitoring Using QuantiFERON®-CMV Assay in Congenital Cytomegalovirus Infection: Correlation With Clinical Presentation and CMV DNA load 160
Combination of Cpb-Hsp70 typing methods reveals genetic divergence between Leishmania infantum strains causing human tegumentary leishmaniasis in northern Italy and central Spain: a retrospective study 159
Cytomegalovirus in pregnancy and the neonate 159
Cmv-specific cell-mediated immunity in immunocompetent adults with primary cmv infection: A case series and review of the literature 159
Non-pathogenic Neisseria species of the oropharynx as a reservoir of antimicrobial resistance: a cross-sectional study 158
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. 158
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 158
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus. 158
Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016 158
Citomegalovirus 157
Molecular detection and genetic characterization of circulating measles virus in northern Italy. 157
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation 156
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 154
Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study. 154
Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. 154
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. 154
Predizione ecografica dell’infezione congenita sintomatica da cytomegalovirus 153
Clinical Diagnostic Testing for Human Cytomegalovirus Infections 152
Non primary versus primary cytomegalovirus infection during pregnancy. 151
Group A rotavirus genotypes in hospital-acquired gastroenteritis in Italy, 2012–14 150
Totale 21.160
Categoria #
all - tutte 115.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.116 0 0 0 0 0 0 0 0 0 186 124 806
2021/20223.967 258 153 237 506 348 195 106 318 176 278 814 578
2022/20234.725 420 541 251 561 378 356 195 317 769 255 377 305
2023/20242.572 150 273 204 186 213 343 241 245 97 237 178 205
2024/20257.398 383 951 589 505 997 409 502 308 220 553 545 1.436
2025/202616.251 1.512 1.843 1.586 1.323 1.713 1.005 1.794 607 3.619 1.249 0 0
Totale 43.479